|
|
|
Insider
Information: |
Granadillo Pedro P |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
258,751 |
|
Indirect Shares
|
118,154 |
|
|
Direct
Value |
$90,543,471 |
|
|
Indirect Value
|
$82,183,363 |
|
|
Total
Shares |
376,905 |
|
|
Total
Value |
$172,726,833 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
First Indiana Corp |
FINB |
Director |
2008-01-02 |
0 |
2004-01-02 |
0 |
Premium* |
|
Haemonetics Corp |
HAE |
Director |
2018-11-08 |
15,335 |
2005-09-02 |
0 |
Premium* |
|
Capricor Therapeutics |
CAPR |
Director |
2007-10-16 |
27,588 |
|
0 |
Premium* |
|
Eli Lilly & Co |
LLY |
Senior Vice President |
2004-09-23 |
106,316 |
2004-09-23 |
98,154 |
Premium* |
|
Dendreon Corp |
DNDN |
Director |
2014-01-03 |
87,251 |
2009-10-07 |
0 |
Premium* |
|
NPS Pharmaceuticals Inc |
NPSP |
Director |
2015-02-21 |
0 |
2013-02-07 |
0 |
Premium* |
|
Immunovant Inc |
IMVT |
Director |
|
0 |
2019-05-09 |
20,000 |
Premium* |
|
Orchestra BioMed Holdings Inc. |
OBIO |
Director |
2020-08-03 |
22,261 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HAE |
Haemonetics Corp |
Director |
|
2015-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,337 |
21,632 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2017-07-27 |
4 |
A |
$39.27 |
$170,000 |
D/D |
4,329 |
31,663 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2017-12-01 |
4 |
OE |
$34.41 |
$244,895 |
D/D |
7,118 |
38,781 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2017-12-01 |
4 |
S |
$57.00 |
$406,184 |
D/D |
(7,118) |
32,381 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2018-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,696 |
33,359 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2018-09-17 |
4 |
OE |
$35.50 |
$964,363 |
D/D |
25,122 |
58,481 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2018-09-17 |
4 |
AS |
$108.92 |
$3,446,909 |
D/D |
(30,824) |
27,657 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2018-11-08 |
4 |
S |
$114.50 |
$1,410,869 |
D/D |
(12,322) |
15,335 |
0 |
- |
|
CAPR |
Capricor Therapeutics |
Director |
|
2007-10-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
27,588 |
|
- |
|
OBIO |
Orchestra BioMed Holdings... |
Director |
|
2020-08-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,261 |
|
- |
|
OBIO |
Orchestra BioMed Holdings... |
Director |
|
2020-08-03 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
22,261 |
|
- |
|
IMVT |
Immunovant Inc |
Director |
|
2019-05-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
20,000 |
|
- |
|
62 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|